ARTICLE | Company News
GeneMedicine deal
February 21, 1995 8:00 AM UTC
Corange International Ltd. paid GMED $2.1 million for an exclusive option to enter into a corporate alliance to develop certain non-viral gene medicines for cancer. The option expires on June 30. GMED...